PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm AGM Presentation, page-27

  1. 208 Posts.
    lightbulb Created with Sketch. 101
    My concern I wanted answered in this AGM was that without Marco they wouldn't have the deal making prowess to get a good deal for owners. That was quickly put to bed with the Plexus and Angel consultancies. The process seems good. I also had a chat with Paul afterwards about safety issues. Specifically I wanted to know about incidence of thrombocytopenia and retinitis pigmentosa that have both been seen with PPS in past. He indicated that both are being specifically monitored in the trial but that to date they have not had a single case of either in recipients. A big tick for safety profile.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.